Optimal designs for two-stage genome-wide association studies.

Area of Science:

• Genetics
• Biostatistics
• Computational Biology

Background:

• Genome-wide association (GWA) studies are essential for identifying genetic variants associated with diseases.
• High genotyping costs present a significant barrier to conducting large-scale GWA studies.
• Staged designs, involving two or more phases of genotyping, are increasingly adopted to manage resources.

Purpose of the Study:

• To develop a strategy for cost-effective two-stage GWA study designs.
• To preserve the statistical power of traditional one-stage GWA studies.
• To minimize genotyping costs considering varying per-genotype expenses between stages.

Main Methods:

• Modeling the impact of the ratio of stage 2 to stage 1 per-genotype costs on study design and overall expense.
• Evaluating trade-offs between statistical power and false positive rates for cost mitigation.
• Simulating different design parameters to identify optimal cost-saving strategies.

Main Results:

• The ratio of genotyping costs between stage 2 and stage 1 significantly influences optimal study design and total cost.
• Increasing stage 2 costs shifts expenses to stage 1, raising overall study costs.
• Cost reductions of approximately 15% can be achieved by slightly decreasing power (99% to 95%) or increasing the false positive rate.

Conclusions:

• A well-designed two-stage GWA study can significantly reduce costs while retaining substantial power.
• Flexibility in power and false positive rate allows for cost optimization based on specific study constraints.
• This strategy enables more accessible and efficient large-scale genetic association studies.